A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
సెన్సెక్స్
77,634.43
▲ +0.12%
నిప్టీ
24,258
▲ +0.11%
బంగారం
₹ 14,710/gm
సిల్వర్
₹ 2,65,000/kg
పెట్రోల్
₹ 115.69
డీజిల్
₹ 103.82
ఎల్పీజీ
₹ 994.00
ముడి చమురు
$ 93.20
USD
₹ 95.72
సెన్సెక్స్
77,634.43
▲ +0.12%
నిప్టీ
24,258
▲ +0.11%
బంగారం
₹ 14,710/gm
సిల్వర్
₹ 2,65,000/kg
పెట్రోల్
₹ 115.69
డీజిల్
₹ 103.82
ఎల్పీజీ
₹ 994.00
ముడి చమురు
$ 93.20
USD
₹ 95.72
Tata India Pharma & HealthCare Fund - Direct Plan
3 Year Absolute Returns
69.18% ↑
NAV (₹) on 20 Aug 2026
38.49
1 Day NAV Change
-0.16%
Risk Level
Very High Risk
Rating
-
Tata India Pharma & HealthCare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Tata Asset Management Ltd.. Launched on 04 Dec 2015, investors can start with a minimum ... Read more
NAV History
Fund Details
Min. SIP Amount
₹150
Inception Date
04 Dec 2015
Min. Lumpsum Amount
₹ 5,000
Fund Age
10 Yrs
AUM
₹ 1,541.42 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
0.97%
Scheme Type
Open Ended
Exit Load
0.25%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,541.42 Cr
Equity
99.13%
Money Market & Cash
0.87%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 62.71% |
| Hospitals & Medical Services | 28.90% |
| Agro Chemicals/Pesticides | 4.85% |
| Personal Care | 1.15% |
| Chemicals - Organic - Others | 0.97% |
| Cash | 0.61% |
| Chemicals - Speciality | 0.55% |
| Treps/Reverse Repo | 0.26% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | 8.59% | ₹ 132.40 | Pharmaceuticals |
| DIVI LABORATORIES LTD | 6.36% | ₹ 98 | Pharmaceuticals |
| HEALTHCARE GLOBAL ENTERPRISES LTD | 5.85% | ₹ 90.21 | Hospitals & Medical Services |
| ABBOTT INDIA LTD | 5.63% | ₹ 86.82 | Pharmaceuticals |
| RAINBOW CHILDRENS MEDICARE LTD | 4.90% | ₹ 75.52 | Hospitals & Medical Services |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | 4.66% | ₹ 71.87 | Pharmaceuticals |
| CIPLA LTD | 4.53% | ₹ 69.81 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD | 4.25% | ₹ 65.48 | Pharmaceuticals |
| MAX HEALTHCARE INSTITUTE LTD | 4.07% | ₹ 62.78 | Hospitals & Medical Services |
| APOLLO HOSPITALS ENTERPRISE LTD | 3.90% | ₹ 60.18 | Hospitals & Medical Services |
| BAYER CROPSCIENCE LTD | 3.26% | ₹ 50.31 | Agro Chemicals/Pesticides |
| FORTIS HEALTHCARE LTD | 3.12% | ₹ 48.13 | Hospitals & Medical Services |
| PFIZER LTD | 3.06% | ₹ 47.12 | Pharmaceuticals |
| MANKIND PHARMA LTD | 3.02% | ₹ 46.53 | Pharmaceuticals |
| SYNGENE INTERNATIONAL LTD | 2.95% | ₹ 45.53 | Pharmaceuticals |
| SAI LIFE SCIENCES LTD | 2.89% | ₹ 44.52 | Pharmaceuticals |
| LUPIN LTD | 2.64% | ₹ 40.76 | Pharmaceuticals |
| ALKEM LABORATORIES LTD | 2.58% | ₹ 39.72 | Pharmaceuticals |
| PROCTER & GAMBLE HEALTH LTD | 2.42% | ₹ 37.25 | Pharmaceuticals |
| FDC LTD | 2.39% | ₹ 36.84 | Pharmaceuticals |
| DR. LAL PATH LABS LTD | 2.17% | ₹ 33.50 | Hospitals & Medical Services |
| GLOBAL HEALTH LTD | 2.13% | ₹ 32.88 | Hospitals & Medical Services |
| CONCORD BIOTECH LTD | 1.91% | ₹ 29.46 | Pharmaceuticals |
| SUMITOMO CHEMICAL INDIA LTD | 1.59% | ₹ 24.49 | Agro Chemicals/Pesticides |
| AJANTA PHARMA LTD | 1.53% | ₹ 23.58 | Pharmaceuticals |
| NEULAND LABORATORIES LTD | 1.25% | ₹ 19.30 | Pharmaceuticals |
| GILLETTE INDIA LTD | 1.15% | ₹ 17.76 | Personal Care |
| METROPOLIS HEALTHCARE LTD | 1.12% | ₹ 17.32 | Hospitals & Medical Services |
| BASF INDIA LTD | 0.97% | ₹ 14.90 | Chemicals - Organic - Others |
| MANIPAL HEALTH ENTERPRISES LTD | 0.97% | ₹ 14.96 | Hospitals & Medical Services |
| JUBILANT PHARMOVA LTD | 0.83% | ₹ 12.73 | Pharmaceuticals |
| DR. AGARWALS HEALTH CARE LTD | 0.67% | ₹ 10.29 | Hospitals & Medical Services |
| CASH / NET CURRENT ASSET | 0.61% | ₹ 9.27 | Others |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | 0.55% | ₹ 8.47 | Chemicals - Speciality |
| BIOCON LTD | 0.52% | ₹ 7.98 | Pharmaceuticals |
| ZIM LABORATORIES LTD | 0.46% | ₹ 7.13 | Pharmaceuticals |
| TREPS | 0.26% | ₹ 3.97 | Others |
| SANOFI INDIA LTD | 0.23% | ₹ 3.53 | Pharmaceuticals |
| ANTHEM BIOSCIENCES LTD | 0.01% | ₹ 0.11 | Pharmaceuticals |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 6.99% | 6.11% | 5.84% | 19.16% |
| Category returns | 4.95% | 7.39% | 6.92% | 23.87% |
Fund Objective
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ... Read more
AMC Details
Name
Tata Asset Management Ltd.
Date of Incorporation
30 Jun 1995
CEO
Mr. Anand Vardarajan
CIO
Mr. Rahul Singh
Type
Pvt.Sector-Indian
Address
1903, B-Wing, Parinee Crescenzo,
G-Block, Bandra Kurla Complex,
Bandra East, Mumbai, Maharashtra, India - 400051
Website
http://www.tatamutualfund.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹30.49 | 31.40% | 174.92% | 0.00% | ₹10,709 | 1.79% |
Very High
|
Top Funds from Tata Asset Management Ltd.
FAQs
What is the current NAV of Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout?
The current Net Asset Value (NAV) of Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout is ₹38.49 as of 20 Aug 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout?
The Assets Under Management (AUM) of Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout is ₹1,541.42 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout?
Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout has delivered returns of 6.11% (1 Year), 19.16% (3 Year), 14.75% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout?
Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout?
The minimum lumpsum investment required for Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹150, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+